Latest News about Biotech
Recent news which mentions Biotech
Syfovre's Competitive Edge Highlights Bright Future For Apellis Pharmaceuticals, Analyst Initiates With Bullish Pitch
October 16, 2024
From Benzinga
Johnson & Johnson's MedTech Challenges Loom Amid Chinese Market Pressures And Orthopedics Overhaul, Analysts Say
October 16, 2024
From Benzinga
GSK Seeks FDA Approval For Oral Antibiotic For Urinary Tract Infections, Probably First In New Class In Over 20 Years
October 16, 2024
From Benzinga
Wave Life Sciences Reveals RNA Editing Breakthrough, Reports First-Ever Clinical Proof-Of-Mechanism In Humans
October 16, 2024
From Benzinga
FDA Puts Speed Breaker On Novavax's COVID/Flu Combo Shot Trial On Concerns Related To Damaged Nerves
October 16, 2024
From Benzinga
Guggenheim's Longstanding Pfizer Ties Tested Amid Starboard Battle
October 16, 2024
From Benzinga
EXCLUSIVE: Alzamend Neuro Reveals Full Data Set From Multiple Ascending Dose Trial For Lead Candidate For Dementia Related to Alzheimer's
October 16, 2024
From Benzinga
FDA Approves NovoCure's Portable Device Producing Tumor-Treating Electric Fields For Previously Treated Lung Cancer Patients
October 16, 2024
From Benzinga
ReproTech LLC Announces New Scientific Advisory Board
October 15, 2024
From PRLog
Biodexa Pharmaceuticals Stock Is Soaring After The Close: What's Driving Shares Higher?
October 15, 2024
From Benzinga
Cancer Drugs Propel J&J Beyond Wall Street Estimates
October 15, 2024
From Benzinga
GSK Sues Moderna Alleging mRNA Vaccine Patent Infringement
October 15, 2024
From Benzinga
Small Cap-MeiraGTx Reveals Encouraging Data From Parkinson's Study Showing Significant, Clinically Meaningful Changes in Key Efficacy Endpoints
October 15, 2024
From Benzinga
Jazz Pharmaceuticals' Zepzelca/Tecentriq Combo Regimen Can Potentially Delay Disease Progression, Extend Survival In Aggressive Form Of Lung Cancer
October 15, 2024
From Benzinga
Bayer Seeks European Approval For Its Menopause Drug
October 15, 2024
From Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
